The role of pineal gland in breast cancer development

Critical Reviews in Oncology/Hematology

Volumn 46, Issue 3, 2003, Pages 221-234

  Anisimov, Vladimir N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Breast cancer; Cancer prevention; Light deprivation; Light at night; Pineal gland, melatonin, peptides

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ALANYLGLUTAMYLASPARTYLGLYCINE; ANDROGEN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; EPITALON; EPITHALAMIN; ESTROGEN DERIVATIVE; ESTROGEN SYNESTROL; MELATONIN; METHYLNITROSOUREA; PINEAL BODY HORMONE; TAMOXIFEN; TETRAPEPTIDE; THIOTEPA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BLINDNESS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SYNTHESIS; EPIDEMIOLOGICAL DATA; ESTRUS CYCLE; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; ILLUMINATION; INHIBITION KINETICS; LIGHT DARK CYCLE; LIGHT EXPOSURE; NIGHT; NONHUMAN; OCCUPATIONAL HAZARD; ONCOGENE; OVARY CYST; PINEAL BODY; PINEAL GLAND FUNCTION; PINEALECTOMY; WORKER;

EID: 0037844514     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(03)00021-0     Document Type: Conference Paper

References (163)

1. Parkin D.M., Bray F.I., Deseva S.S. Cancer burden in the year 2000. The global picture. Eur. J. Cancer. 37:2000;S4-S66.
2. Kerenyi N.A., Pandula E., Feuer G. Why the incidence of cancer is increasing: the role of 'light pollution'. Med. Hypoth. 33:1990;75-78.
3. Stevens R.G. Circadian disruption and breast cancer. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;511-517 Springer, Berlin.
4. Stevens R.G., Rea M.S. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 12:2001;279-287.
5. Arendt J. Melatonin and the mammalian pineal gland. 1995;Chapman and Hall, London.
6. Lakin-Thomas P.L. Circadian rhythms: new functions for old clock genes? Trends Gene. 16:2000;135-142.
7. Pandi-Perumal S.R., Seils L.K., Kayumov L., et al. Senescence, sleep, and circadian rhythms. Ageing Res. Rev. 1:2002;559-604.
8. Hurd M.W., Ralph M.R. The significance of circadian organization for longevity in the golden hamster. J. Biol. Rhyth. 13:1998;430-436.
9. Thelle D.S., Forde O.H., Try K., Lehmann E.H. The Tromso Heart Study. Acta Med. Scand. 200:1976;107-118.
10. Theorell T., Akerstedt E. Day and night work: changes in cholesterol, uric acid, glucose and potassium in serum and circadian patterns of urinary catecholamine excretion. Acta Med. Scand. 200:1976;47-53.
11. Knutsson A., Akerstedt Y., Jonsson B. Prevalence of risk factors for coronary artery disease among day and shift workers. Scand. J. Work Environ. Health. 14:1988;317-321.
12. Kawachi I., Colditz G.A., Stampfer M.J., et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation. 92:1995;3178-3182.
13. Fujino Y., Mizoue T., Izumi H., Kumashiro M., Hasegawa T., Yoshimura T. Job stress and mental health among permanent night workers. J. Occup. Health. 43:2001;301-306.
14. Komarov F.I., Rapoport S.I., Malinovskaya N.K., et al. Ulceroprotective effect of melatonin during artificial simulation of desynchronization in rats. Vestnik. Russ. Acad. Med. Sci. 8:2000;21-25.
15. Aschoff J., von Saint Paul U., Wever R. Die Lebesdauer von Fliegen inter dem Einfluss von Zeitverschiebungen. Naturwissenschaften. 58:1971;574.
16. Sheeba V., Sharma V.K., Shubha K., Chandrashekaran M.K., Joshi A. The effect of different light regimes on adult life span in Drosophila melanogaster is partly mediated through reproductive output. J. Biol. Rhyth. 15:2000;380-392.
17. Hoffman J.C. Light and reproduction in the rat. Effect of early lighting on response measured in adult females. Biol. Reprod. 8:1973;473-480.
18. Hoffman J.C. Light and reproduction in the rat: effects of photoperiod length on albino rats from two different breeders. Biol. Reprod. 2:1970;255-261.
19. Hardy D.F. The effect of constant light on the estrus cycle and behavior of the female rat. Physiol. Behav. 5:1970;421-425.
20. Murthy A.S.K., Russfield A.B. Endocrine changes in two strains of mice exposed to constant illumination. Endocrinology. 86:1970;914-917.
21. Jochle W. Trends in photophysiologic concepts. Ann. N.Y. Acad. Sci. 117:1964;88-104.
22. Smirnova IO. Experimental Bases of Treatment of Mastopathy with Iodine Microdoses. PhD Thesis. All-Union Cancer Center, Moscow, 1966.
23. Ird E.A. Follicular cysts of the ovary and dyshormonal tumors. 1966;Meditsina, Leningrad.
24. Lazarev N.I., Ird E.A., Smirnova I.O. Experimental models of endocrine gynecological diseases. 1976;Meditsina, Moscow.
25. Kothari L., Shah P.N., Mhatre M.C. Effect of continuous light on the incidence of 9,10-dimethyl-1,2-benzanthracene induced mammary tumors in female Holtzman rats. Cancer Lett. 16:1982;313-317.
26. Anisimov V.N., Zhukova O.V., Beniashvili D.S.h, Bilanishivili V.G., Menabde M.Z. Light deprivation, electromagnetic fields and mammary carcinogenesis. Adv. Pineal Res. 7:1994;229-234.
27. Brainard G.C., Kaver R., Kheifets L.I. The relationship between electromagnetic field and light exposure to melatonin and breast cancer risk: a review of the relevant literature. J. Pineal Res. 26:1999;65-100.
28. Coudert B. Circadian concepts in normal and neoplastic breast. Chronobiol. Int. 19:2002;221-235.
29. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrin. Rev. 12:1991;151-180.
30. Reiter R.J. Potential biological consequences of excessive light exposure: melatonin suppression, DNA damage, cancer and neurodegenerative diseases. Neuroendocrinol. Lett. 23:(Suppl 2):2002;9-13.
31. Davis, Kaune W.T., Mirick D.K., Chen C., Stevens R.G. Residental magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. Am. J. Epidemiol. 154:2001;591-600.
32. Graham C., Cook M.R., Gerkovich M.M., Sastre A. Examination of the melatonin hypothesis in women exposed at night to EMF or bright light. Environ. Health Perspect. 109:2001;501-507.
33. Glyckman G., Levin R., Brainrad G.C. Ocular input for human melatonin regulation: relevance to breast cancer. Neuroendocrinol. Lett. 23:(Suppl 2):2002;17-22.
34. Yu HS, Reiter RJ, editors. Melatonin. Biosynthesis, physiological effects, and clinical applications. Boca Raton, FL: CRC Press, 1993.
35. Davis S., Mirck D.K., Stevens R.G. Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst. 93:2001;1557-1562.
36. Schernhammer E.S., Laden F., Speizer F.E., et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl. Cancer Inst. 93:2001;1563-1568.
37. Pukkala E., Auvinen H., Wahlberg G. Incidence of cancer among Finnish airline cabin attendants, 1967-92. Br. Med. J. 311:1995;649-652.
38. Tynes T., Hannevik M., Andersen A., Vistnes A., Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control. 7:1996;197-204.
39. Hansen J. Increased breast cancer risk among women who work predominantly at night. Ann. Epidemiol. 12:2001;74-77.
40. Rafnsson V., Tulinius H., Jonasson J., Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Cause Control. 12:2001;95-101.
41. Cohen M., Lippman M., Chabner R. Role of pineal gland in aetiology and treatment of breast cancer. Lancet. 2:1978;814-816.
42. Stevens R.G., Davis S. The melatonin hypothesis: electric power and breast cancer. Environ. Health Perspect. 104:(Suppl 1):1996;135-140.
43. Aschheim P. Everitt A.V., Burgess J.A. Aging in the hypothalamic-hypophyseal-ovarian axis in the rat. 1976;376-392 Charles C Tomas, Springfield.
44. Anisimov V.N. Blastomogenesis in persistent-estrus rats. Vopr. Onkol. 8:1971;67-75.
45. Anisimov V.N. Carcinogenesis and aging. 2:1987;CRC Press, Boca Raton.
46. Dilman V.M., Anisimov V.N. Hypothalamic mechanisms of ageing and of specific age pathology-I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp. Gerontol. 14:1979;161-174.
47. Dilman V.M. Development, aging and disease. A new rationale for an intervention strategy. 1994;Harwood Academic, Chur.
48. Rossmanith W.G. Gonadotropin secretion during aging in women: review article. Exp. Gerontol. 30:1996;369-381.
49. Baturin D.A., Alimova I.N., Anisimov V.N., et al. Effect of light regime and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuroendocr. Lett. 22:2001;439-445.
50. Bartsch C., Bartsch H. Effects of melatonin and constant light on the development of spontaneous endometrial carcinomas in aging BDII/Han rats appear to be exerted by modulation of maturation of the reproductive system. Z. Gerontol. Geriatr. 32:(Suppl 2):1999;II/5.
51. Dauchy R.T., Sauer L.A., Blask D.E., Vaughan G.M. Light contamination during the dark phase in photoperiodically controlled animal rooms: effect on tumor growth and metabolism in rats. Lab. Anim. Sci. 47:1997;511-517.
52. Khaetski I.K. Effect of hypothalamo-pituitary lesions induced by constant illumination on development of induced mammary tumors in rats. Vopr. Eksp. Onkol. (Kiev). 1:1965;87-93.
53. Hamilton T., Sneddon A. Environmental light and DMBA-induced rat mammary tumours. Br. J. Surg. 55:1968;71-76.
54. Hamilton T. Influence of environmental light and melatonin upon mammary tumour induction. Br. J. Surg. 56:1969;764-766.
55. Bell J.A., Sneddon A., Hamilton T. Influence of light and 9,10-dimethylbenz(a) anthracene on rat ovarian steroidogenesis: neutral steroids. Biochem. J. 110:1968;29p-30p.
56. Smyth B.J., Sneddon A., Hamilton T. Influence of light and 9,10-dimethylbenz(a)-anthracene on rat ovarian steroidogenesis: phenolic steroids. Biochem. J. 110:1968;28p-29p.
57. Kothari L. Effect of melatonin on the mammary gland morphology, DNA synthesis, hormone profiles and incidence of mammary cancer in rats. Gupta D., Attanasio A., Reiter R.J. The pineal gland and cancer. 1988;210-219 Brain Research Promotion, London.
58. Jull J.W. The effect of infection, hormonal environment, and genetic constitution on mammary tumor induction in rats by 7,12-dimethylbenz(a)anthracene. Cancer Res. 26:1966;2368-2373.
59. Shah P.N., Mhatre M.C., Kothari L. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res. 44:1984;3403-3407.
60. Mhatre M.C., Shah P.N., Juneja H.S. Effect of varying photoperiods on mammary morphology, DNA synthesis and hormonal profile in female rats. J. Natl. Cancer Inst. 72:1984;1411-1416.
61. Anderson L.E., Morris J.E., Sasses L.B., Stevens R.G. Effect of constant light on DMA mammary tumorigenesis in rats. Cancer Lett. 148:2000;121-126.
62. Russo I.H., Russo J. Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 104:1996;938-967.
63. Blask D.E. An overview on the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;309-342 Springer, Berlin.
64. Travlos G.S., Wilson R.E., Murrell J.A., Chignell C.F., Boorman G.A. The effect of short intermittent light exposures on the melatonin circadian rhythm and NMU-induced breast cancer in female F344/N rats. Toxicol. Pathol. 29:2001;126-136.
65. Van den Heiligenberg S., Depres-Brummer P., Barbason H., Claustrat B., Reynes M., Levi F. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci. 64:1999;2523-2534.
66. Beniashvili D.S., Benjamin S., Baturin D.A., Anisimov V.N. Effect of light/dark regimen on N-nitrosoethylurea-induced transplacental carcinogenesis in rats. Cancer Lett. 163:2001;51-57.
67. Kuralasov A.K. Effect of dark adaptation on carcinogenesis and efficacy of treatment DMBA-induced mammary tumor. Izvestia Akad. Nauk. Kazakh. SSR Ser. Biol. 4:1979;79-82.
68. Kuralasov AK. Experimental Bases for Application of Artificial Photoregimen for Breast Cancer Treatment in Kazakhstan. Diss Doctor Med Sci. Moscow: All-Union Cancer Center, 1990.
69. Blask D.E., Hill S.M., Pelletier D.B. Oncostatic signaling by the pineal gland and melatoninin the control of breast cancer. Gupta D., Attanasio A., Reiter R.J. The pineal gland and cancer. 1988;221-232 Brain Research Promotion, London.
70. Blask D.E. The pineal: an oncostatic gland. Reiter R.J. The pineal gland. 1984;253-284 Raven Press, New York.
71. Sanchez-Barcelo E.J., Cos S., Mediavilla M.D. Influence of pineal function on the initiation and growth of hormone-dependent breast tumors. Possible mechanisms. Gupta D., Attanasio A., Reiter R.J. The pineal gland and cancer. 1988;221-232 Brain Research Promotion, London.
72. Hahn R.A. Profound bilateral blindness and the incidence of breast cancer. Epidemiology. 2:1991;108-210.
73. Feychting M., Oosterlund B., Ahlbom A. Reduced cancer incidence among the blind. Epidemiology. 9:1998;490-494.
74. Pukkala E., Verkasalo P.K., Ojamo M., Rudanko S.L. Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes Control. 10:1999;13-20.
75. Verkasalo P.K., Pukkala E., Stevens R.G., Ojamo M., Rudanko S.L. Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br. J. Cancer. 80:1999;1459-1460.
76. Cos S., Sanchez-Barcel E.J. Melatonin and mammary pathological growth. Front. Neuroendocrinol. 21:2000;133-170.
77. Cos S., Sanchez-Barcelo E.J. In vitro effects of melatonin on tumor cells. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;221-239 Springer, Berlin.
78. Blask D.E., Hill S.M. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J. Neural. Transm. (Suppl). 21:1986;433-449.
79. L'Hermite-Baleriaux M., de Launoit Y. Is melatonin really an in vitro inhibitor of human breast cancer cell proliferation in vitro. Cell Dev. Biol. 28A:1992;583-584.
80. Molis T., Walters M.R., Hill S.M. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cells. Int. J. Oncol. 3:1993;687-694.
81. Lemus-Wilson A., Kelly P.A., Blask D.E. Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br. J. Cancer. 72:1995;1435-1440.
82. Haus E., Dumitriu L., Nicolau G.Y., Bologa S., Sackett-Lundeen L. Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer. Chronobiol. Int. 18:2001;709-727.
83. Anisimov V.N., Morozov V.G., Khavinson V.Kh., Dilman V.M. Correlation of anti-tumor activity of pineal and hypothalamic extracts, melatonin and sygetin in mouse transplantable mammary tumor. Vopr. Onkol. 10:1973;99-101.
84. Aubert C., Janiaud P., Lecalvez J. Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. J. Neural. Trans. 47:1980;121-130.
85. Blask D.E., Hill S.M., Orstead K.M., Massa J.S. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotion phase of 7,12-dimethylbenz[a]-anthracene-(DMBA)-induced mammary tumorigenesis. J. Neural. Transm. 67:1986;125-138.
86. Kothari L. Influence of chronic melatonin on 9,10-dimethyl-1,2-benzanthrazene-induced mammary tumors in female Holtzman rats exposed to continuous light. Oncology. 44:1987;64-66.
87. Subramanian A., Kothari L. Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzathracene (DMBA)-induced rat mammary gland carcinogenesis. Anticancer Drugs. 2:1991;297-303.
88. Tamarkin L., Cohen D., Roselle C., Reichert M. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat. Cancer Res. 41:1981;4432-4436.
89. Welsch C.W. Host factors affecting the growth of carcinogen-induced rats mammary carcinomas: a review and tribute to Charles Benton Huggins. Cancer Res. 45:1985;3415-3443.
90. Blask D.E., Pelletier D.B., Hill S.M., et al. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J. Cancer Res. Clin. Oncol. 117:1991;526-532.
91. Kothari A., Borges A., Kothari L. Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation nitroso-methylurea-induced mammary tumour in rats. Eur. J. Cancer Prev. 4:1995;497-500.
92. Kothari A., Borges A., Ingle A., Kothari L. Combination of melatonin and tamoxifen as a chemoprophylaxis against N-nitroso-N-methylurea-induced rat mammary tumors. Cancer Lett. 111:1997;59-66.
93. Kubatka P., Bojkova B., Mocikova-Kalicka K., et al. Effect of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)-anthracene, respectively, in female Sprague-Dawley rats. Folia Biol. 47:2001;5-10.
94. Subramanian A., Kothari L. Melatonin, a suppressor of spontaneous murine mammary tumors. J. Pineal Res. 10:1991;136-140.
95. Anisimov V.N., Zavarzina N.Y., Zabezhinski M.A., et al. Melatonin increases both life span and tumor incidence in female CBA mice. J. Gerontol. Biol. Sci. 56A:2001;B311-B323.
96. Mediavilla M.D., Guezmez A., Ramos S., Kothari L., Garijo F., Sanchez-Barcelo E.J. Effect of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene. J. Pineal Res. 22:1997;86-94.
97. Rao G.N., Ney E., Herbert R.A. Effect of melatonin and linoleic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Res. Treatm. 64:2000;287-296.
98. Mockova K., Mnichova M., Kubatka P., Bojkova B., Ahlers I., Ahlersova E. Mammary carcinogenesis induced in Wistar:Han rats by the combination of ionizing radiation and dimethylbenz(a)anthracene: prevention with melatonin. Neoplasma. 47:2000;227-229.
99. Musatov S.V., Anisimov V.N., Andre V., Vigreuz C., Godard T., Sichel F. Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay). Cancer Lett. 138:1999;37-44.
100. Bartsch H., Bartsch C., Mecke D., Leppert T.H. Differential effect of melatonin on early and advanced passages of a DMBA-induced mammary carcinoma in the female rat. Adv. Pineal Res. 7:1994;247-252.
101. Lissoni P., Barni S., Meregalli S., et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br. J. Cancer. 71:1995;854-856.
102. Lissoni P. Efficacy of melatonin in the immunotherapy of cancer using interleukin-2. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;463-475 Springer, Berlin.
103. Hrushesky W.J.M. Melatonin cancer therapy. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;476-508 Springer, Berlin.
104. Karasek M., Kuzdak K., Cywinski J., Zylinska K., Smialowska A., Pluzanska A. Effect of melatonin administration in advanced breast cancer patients - preliminary report. Neuroendocrinol. Lett. 19:1998;15-19.
105. Bartsch C., Bartsch H., Karasek M. Melatonin in clinical oncology. Neroedocrinol. Lett. 23:(Suppl 1):2002;30-38.
106. Bartsch C., Bartsch H., Gupta D. Pineal melatonin synthesis and secretion during induction and growth of mammary cancer in female rats. Gupta D., Wollmann H.A., Ranke M.B. Neuroendocrinology: new frontiers. 1990;326-332 Brain Research Promotion, London and Tubingen.
107. Bartsch C., Bartsch H., Lippert T.H., Gupta D. Effect of the mammary carcinogen 7,12-dimethylbenz[a]anthracene on pineal melatonin biosynthesis, secretion and peripheral metabolism. Neuronedocrinology. 52:1990;538-544.
108. Praast G., Bartsch C., Bartsch H., Mecke D., Lippert T.H. Hepatic hydroxylation of melatonin in the rat is induced by phenoobarbital and 7,12-dimethylbenz[a]anthracene-implications for cancer etiology. Experientia. 51:1995;349-355.
109. Bartsch H., Bartsch C., Mecke D. The modulation of melatonin in tumor-bearing animals: underlying mechanisms and possible significance for prognosis. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;197-209 Springer, Berlin.
110. Blask D.E., Sauer L.A., Dauchy R.T. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Top. Med. Chem. 2:2002;113-132.
111. Blask D.E., Dauchy R.T., Sauer L.A., Kraus J.A., Brainard G.C. Light during darkness, melatonin suppression and cancer progression. Neuroendocrinol. Lett. 23:(Suppl 2):2002;52-56.
112. Pawlikowski M., Winczyk K., Karasek M. Oncostatic action of melatonin: facts and question marks. Neuroendocrinol. Lett. 23:(Suppl 1):2002;24-29.
113. Reiter R.J. The pineal and its hormones in the control of reproduction in mammals. Endocrin. Rev. 1:1980;109-131.
114. Wolden-Hanson T., Mitton D.R., McCants R.L., et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology. 141:2000;487-497.
115. Hill S.M., Kiefer T., Teplitzky S., Spriggs L.L., Ram P.T. Modulation of the estrogen response pathway in human breast cancer cells by melatonin. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;343-358 Springer, Berlin.
116. Musatov S.A., Anisimov V.N., Andre V., et al. Modulatory effects of melatonin on genotoxic response of reference mutagens in the Ames test and the comet assay. Mutat. Res. 417:1998;75-84.
117. Vijayalaxmi, Reiter R.J., Meltz M.L. Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes. Mutat. Res. 397:1998;203-208.
118. Reiter R.J. Reactive oxygen species, DNA damage, and carcinogenesis: intervention with melatonin. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;442-455 Springer, Berlin.
119. Eck-Enriquez K., Kiefer T.L., Spriggs L.L., Hill S.M. Pathways through which a regimen of melatonin and retinoic acid induced apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 61:2000;229-239.
120. Lissoni P., Rovelli F., Malugani F., Bukovec R., Conti A., Maestroni G.J.M. Antiangiogenic activity of melatonin in advanced cancer patients. Neuroendocrinol. Lett. 22:2001;45-47.
121. Karbownik M. Potential anticarcinogenic action of melatonin and other antioxidants mediated by antioxidative mechanisms. Neuroendocrinol. Lett. 23:(Suppl 1):2002;39-44.
122. Sauer L.A., Dauchy R.T., Blask D.E. Polysaturated fatty acids, melatonin, and cancer prevention. Biochem. Pharmacol. 61:2001;1455-1462.
123. Maestroni G.J.M. Melatonin and the immune system: therapeutic potential in cancer, viral diseases, and immunodeficiency states. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;384-394 Springer, Berlin.
124. Skwarlo-Sonta K. Melatonin in immunity: comparative aspects. Neurondocrinol. Lett. 23:(Suppl 1):2002;61-66.
125. Liu F., Ng T.B., Fung M.C. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J. Neural Transm. 108:2001;397-405.
126. Anisimov S.V., Boheler K.R., Anisimov V.N. Study on the effect of melatonin on gene expression in mouse heart using microarray technology. Dokl. Russ. Acad. Sci. 383:2002;276-281.
127. Ram P.T., Dai J., Yuan L., et al. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett. 179:2002;141-150.
128. Rodriguez-Reynoso S., Leal C., Portilla E., Olivares N., Muniz J. Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumornecrosis factor-α and nitric oxide. J. Surg. Res. 100:2001;141-149.
129. Prunett-Marcassus B., Ambid L., Vieguere-Bascands N., Penicaud L., Castella L. Evidence for a direct effect of melatonin on mitochondrial genome expression of Siberian hamster adipocytes. J. Pineal Res. 30:2001;108-115.
130. Michel J.J., Xiong Y. Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ. 9:1998;435-449.
131. Krek W. Proteolysis and the G1-S transition: the SCF connection. Curr. Opin. Genet. Dev. 8:1998;36-42.
132. Deshaies R.J. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15:1999;435-467.
133. Burnatowska-Hledin M., Zhao P., Capps B., et al. VACM-1, a cullin gene family member, regulates cellular signaling. Am. J. Physiol. Cell Physiol. 279:(1):2000;C266-273.
134. Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol. Life Sci. 55:(5):1999;735-750.
135. Benson B., Matthew M.J., Rodin A.E. Studies on a non-melatonin pineal antiginadotropin. Acta Endocrinol. 69:1972;257-266.
136. Blask D.E., Vaughan M.K., Reiter R.E. Pineal peptides and reproduction. Relkin R. The pineal gland. 1983;201-224 Elsevier, Amsterdam.
137. Noteborn H.P.J.M., Bartsch H., Bartsch C., et al. Partial purification of a low molecular weight ovine pineal compound(s) with an inhibiting effect on the growth of human melanoma cells in vitro. J. Neural Transm. 73:1988;135-155.
138. Catrina S.B., Catrina A.I., Sirzen F., et al. A cytotoxic, apoptotic, low-molecular weight factor from pineal gland. Life Sci. 65:1999;1047-1057.
139. Bartsch H., Bartsch C., Mecke D., Leppert T.H. Serial transplants of DMBA-induced mammary tumours in Fischer rats as model system for human breast cancer: I. Effect of melatonin and pineal extracts on slow- and fast-growing passages - in vivo and in vitro studies. Adv. Pineal Res. 8:1994;473-478.
140. Ebels I., Benson B. A survey of the evidence that melatonin and unidentified pineal substances affect neoplastic growth. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;275-293 Springer, Berlin.
141. Morozov V.G., Khavinson V.Kh. Peptide Bioregulators (25-years Experience of Experimental and Clinical Study). 1996;Nauka, St. Petersburg.
142. Khavinson V.Kh., Morozov V.G., Anisimov V.N. Experimental studies of the pineal gland preparation epithalamin. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. 2001;294-306 Springer, Berlin.
143. Dilman V.M., Anisimov V.N., Ostroumova M.N., Khavinson V.Kh., Morozov V.G., Azarova M.A. Study on the anti-tumor effect of polypeptide pineal extract. Oncology. 36:1979;274-280.
144. Anisimov V.N., Khavinson V.Kh. Effect of polypeptide pineal preparation on life span and spontaneous tumor incidence in old female rats. Dokl. Akad. Nauk. USSR. 319:1991;250-254.
145. Anisimov V.N., Khavinson V.Kh., Morozov V.G. Carcinogenesis and aging. IV. Effect of low-molecular weight factors of thymus, pineal gland and anterior hypothalamus on immunity, tumor incidence and life span of C3H/Sn mice. Mech. Ageing Dev. 19:1982;245-258.
146. Anisimov V.N., Loktionov A.S., Khavinson V.Kh., Morozov V.G. Effect of low-molecular-weight factors of thymus and pineal gland on life span and spontaneous tumour development in female of different age. Mech. Ageing Dev. 49:1989;245-257.
147. Anisimov V.N., Ostroumova M.N., Dilman V.M. Inhibition of carcinogenic effect of 7,12-dimethylbenz(a)anthracene with buformin, diphenylhydantoin, polypeptide pineal extract and L-DOPA in female rats. Bull. Exp. Biol. Med. 89:1980;723-725.
148. Anisimov V.N., Miretski G.I., Morozov V.G., Khavinson V.K.h. Effect of polypeptide factors of thymus and epiphysis on radiation carcinogenesis. Bull. Exp. Biol. Med. 94:1982;26-29.
149. Anisimov V.N., Khavinson V.Kh., Morozov V.G. Twenty years of study on effects of pineal peptide preparation: epithalamin in experimental gerontology and oncology. Ann. N.Y. Acad. Sci. 719:1994;483-493.
150. Slepushkin V.D., Anisimov V.N., Khavinson V.Kh., Morozov V.G., Vasiliev N.V., Kosykh V.A. Pineal gland, immunity and cancer (Theoretical and clinical aspects). 1990;Tomsk University, Tomsk.
151. Khavinson V.Kh., Izmailov D.M., Obukhova L.K., Malinin V.V. Effect of epithalon on lifespan increase in Drosophila melanogaster. Mech. Ageing Dev. 120:2000;141-149.
152. Anisimov V.N., Khavinson V.Kh., Alimova I.N., Provinciali M., Mancini R., Franceschi C. Epitalon inhibits development of tumors and expression of HER-2/neu oncogene in mammary tumors in transgenic mice with accelerated aging. Bull. Exp. Biol. Med. 132:2002;56-59.
153. Anisimov V.N., Arutjunyan A.V., Khavinson V.Kh. Effects of pineal peptide preparation Epithalamin on free radical processes in humans and animals. Neuroendocrinol. Lett. 22:2001;11-20.
154. Khavinson V.Kh., Goncharova N.D., Lapin B.A. Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys. Neuroendocrinol. Lett. 22:2001;251-254.
155. Khavinson V.Kh., Kvetnoi I.M., Popuchiev V.V., Yuzhakov V.V., Kotlova L.N. Effect of pineal peptides on neuroendocrine system after pinealectomy. Arkhiv. Pathol. 63:(3):2001;18021.
156. Khavinson V.Kh., Yakovleva N.D., Popuchiev V.V., Kvetnoi I.M., Ymanokhina R.P. Reparative effect of epitalon on pineal ultrastructure in gamma-irradiated rats. Bull. Exp. Biol. Med. 131:2001;81-85.
157. Anisimov V.M., Khavinson V.Kh., Mikhalski A.I., Yashin A.I. Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice. Mech. Ageing Dev. 122:2001;41-68.
158. Rosenfeld S.V., Togo E.F., Mikheev V.S., et al. Effect of Epitalon on chromosome lesion incidence in senescence accelerated (SAM) mice. Bull. Exp. Biol. Med. 133:2002;320-322.
159. Anisimov S.V., Boheler K.R., Khavinson V.Kh., Anisimov V.N. Study on the effect of peptides Vilon and Epitalon on gene expression in mouse heart using microarray technology. Bull. Exp. Biol. Med. 133:2002;340-347.
160. Anisimov V.N., Khavinson V.Kh., Popovich I.G., Zabezhinski M.A. Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. Cancer Lett. 183:2002;1-8.
161. Erren T.C. Does light cause internal cancers? - The problem and challenge of an ubiquitous exposure. Neuroendocrinol. Lett. 23:(Suppl 2):2002;61-70.
162. Poole C. The darkness at the end of the tunnel: summary and evaluation of an International Symposium on Light Endocrine Systems and Cancer. Neuroendocrinol. Lett. 23:(Suppl 2):2002;71-78.
163. Anisimov V.N., Hansen J. Light, endocrine systems and cancer - A meeting report. Neuroendocrinol. Lett. 23:(Suppl 2):2002;84-87.